Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |